Continuous Delivery Room Skin-to-skin-study for Moderate and Late Preterm Infants
COSY
1 other identifier
interventional
60
1 country
1
Brief Summary
The goal of this randomized controlled trial is to compare the effect of direct skin-to-skin contact in moderate and late preterm infants. The main questions it aims to answer are:
- does skin-to-skin contact in moderate and late preterm infants influence gene expression in the stress signaling pathway?
- does skin-to-skin contact in moderate and late preterm infants improve the short- and long-term outcome? Participants will either get immediate separation after vaginal birth or receive immediate skin-to-skin contact. Researchers will compare these two groups to answer the proposed questions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 13, 2023
CompletedFirst Posted
Study publicly available on registry
August 3, 2023
CompletedStudy Start
First participant enrolled
August 4, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
February 20, 2026
October 1, 2025
3.4 years
July 13, 2023
February 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
gene expression in candidate genes of the stress signalling pathway
DNA will be extracted from peripheral white blood cells and mucosal epithelial cells. The expression of candidate genes of the stress signaling pathways are investigated. The candidate genes are glucocorticoid receptor (NR3C1), corticotropin releasing hormone (CRH), corticotropin-releasing hormone receptor 1 and 2 (CRHR1/2), serotonin transporter (slc6a4), vasopressin and brain-derived neurotrophic factor.
36 to 72 hours after birth
gene expression in candidate genes of the stress signalling pathway
DNA and RNA will be extracted from mucosal epithelial cells. The expression of candidate genes of the stress signaling pathways are investigated. The candidate genes are glucocorticoid receptor (NR3C1), corticotropin releasing hormone (CRH), corticotropin-releasing hormone receptor 1 and 2 (CRHR1/2), serotonin transporter (slc6a4), vasopressin and brain-derived neurotrophic factor. Furthermore a whole-genome methylation will be analysed.
corrected 6 months of age
gene expression in candidate genes of the stress signalling pathway
DNA will be extracted from mucosal epithelial cells. The expression of candidate genes of the stress signaling pathways are investigated. The candidate genes are glucocorticoid receptor (NR3C1), corticotropin releasing hormone (CRH), corticotropin-releasing hormone receptor 1 and 2 (CRHR1/2), serotonin transporter (slc6a4), vasopressin and brain-derived neurotrophic factor.
corrected 24 months of age
Secondary Outcomes (10)
mother-child-interaction
corrected 6 months of age
General Movements
corrected 3 months of age
maternal depression
at inpatient discharge (assessed from 3 to 60 days of life), corrected 6 and 24 months of age
social support
at inpatient discharge (assessed from 3 to 60 days of life), corrected 24 months of age
socio-economic status
at inpatient discharge (assessed from 3 to 60 days of life)
- +5 more secondary outcomes
Study Arms (2)
Standard care
NO INTERVENTIONAfter delivery the infant will be separated from the mother and placed on a primary care unit in another room to monitor the cardiopulmonary adaption for at least 20 minutes.
skin-to-skin contact
EXPERIMENTALAfter delivery the infant will be put skin-to-skin on the mother's breast in comfort position for 60 minutes. The cardiopulmonary adaption will be monitored and supervised by the attending neonatologist and nurse.
Interventions
Immediately after delivery the infant will receive skin-to-skin contact with the mother.
Eligibility Criteria
You may qualify if:
- preterm birth between gestational age of 32 0/7 and 36 6/7 weeks
- vaginal delivery
- singleton
- informed consent before birth
You may not qualify if:
- malformations or syndromes of the infant
- resuscitation of the infant
- maternal psychological or severe physical illness
- lack of German language skills
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University hospital of Cologne, Department of Neonatology
Cologne, Northrhine-westfalia, 50931, Germany
Related Publications (2)
Mehler K, Hucklenbruch-Rother E, Trautmann-Villalba P, Becker I, Roth B, Kribs A. Delivery room skin-to-skin contact for preterm infants-A randomized clinical trial. Acta Paediatr. 2020 Mar;109(3):518-526. doi: 10.1111/apa.14975. Epub 2019 Sep 16.
PMID: 31423649BACKGROUNDHucklenbruch-Rother E, Vohlen C, Mehdiani N, Keller T, Roth B, Kribs A, Mehler K. Delivery room skin-to-skin contact in preterm infants affects long-term expression of stress response genes. Psychoneuroendocrinology. 2020 Dec;122:104883. doi: 10.1016/j.psyneuen.2020.104883. Epub 2020 Sep 24.
PMID: 33027708BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Katrin Mehler, PD Dr.
University of Cologne
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Due to the nature of the intervention blinding of participant and care provider is not possible. The investigators are part of the care providing team.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
July 13, 2023
First Posted
August 3, 2023
Study Start
August 4, 2023
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2028
Last Updated
February 20, 2026
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share